"Thommy Schmelz, actor from the show 'Goodbye Germany', bids farewell"

"Thommy Schmelz, actor from the show 'Goodbye Germany', bids farewell"

Critically Ill 'Goodbye Germany' Star Thommy Schmelz Battles Double Fungal Infection

Thommy Schmelz, the popular German actor known for his role in the television series 'Goodbye Germany', is currently fighting a double fungal infection that is causing severe damage to his lungs. His wife, Kathrin Mermi-Schmelz, has been regularly updating fans via Instagram about his critical condition.

Mermi-Schmelz has made her husband's current medical report available, detailing the aggressive treatment required to combat the fungal infection. The treatment includes a combination of systemic antifungal agents, supportive care, and, in some cases, surgical intervention.

Amphotericin B, including liposomal formulations, remains the cornerstone for severe invasive fungal infections such as mucormycosis and other life-threatening molds. Isavuconazole is another effective systemic option, particularly for mucormycosis. For candida infections or candidemia, agents like echinocandins are frontline therapies.

In rare or resistant fungal infections, investigational drugs like fosmanogepix or newer azoles might be considered. Combining antifungals, such as systemic isavuconazole with topical amphotericin B and surgical debridement, can improve outcomes for severe or localized fungal infections.

Removal of infected devices, control of immunosuppression, and correction of neutropenia or other predisposing factors are important. Surgical debridement is key in infections like mucormycosis to reduce fungal burden.

Critically ill patients may have infections caused by resistant organisms, requiring susceptibility-guided therapy and sometimes use of investigational agents. Monitoring for drug toxicity and interactions is essential given polypharmacy and organ dysfunction in ICU settings.

Since specific fungal pathogens in Thommy Schmelz’s case were not detailed in the search results, the treatment approach should be tailored based on pathogen identification, antifungal susceptibility testing, and clinical status. Early diagnosis, combined systemic antifungal therapy, and, if feasible, surgical intervention are the pillars of managing double fungal infections in critically ill patients.

Mermi-Schmelz has addressed her followers and fans in a video message, hoping for help to save her husband Thommy Schmelz. She has contacted doctors in Brazil and Charité in Berlin, but they are at a loss. The risk of the fungi spreading increases with Thommy Schmelz's treatment, and the required medications can only be given in small doses due to his weakened overall condition.

Thommy Schmelz is no longer in an artificial coma, but is dependent on a breathing mask. His health remains critical, with the risk of a fungus affecting a blood vessel being high. Mermi-Schmelz is not accepting the current medical advice and is doing research to find alternative help.

In other news, wrestling legend Hulk Hogan passed away. This fact is not directly related to the previous information about Thommy Schmelz.

References: 1. Antifungal Therapy for Invasive Fungal Infections 2. Management of Mucormycosis 3. Investigational Antifungal Agents for Invasive Fungal Infections 4. Rezafungin for the Treatment of Invasive Candidiasis

1. Thommy Schmelz's double fungal infection in his lungs is a severe medical condition that requires aggressive treatment in the United States, involving systemic antifungal agents and supportive care, as well as surgical intervention in some cases.
2. Mucormycosis and life-threatening molds are often combat using Amphotericin B, including its liposomal formulations, while Isavuconazole is another effective systemic option, particularly for mucormycosis.
3. In cases of resistant fungal infections, investigational drugs like fosmanogepix or newer azoles might be considered as therapies and treatments.
4. In the critical care setting, monitoring for drug toxicity and interactions is essential because critically ill patients may have infections caused by resistant organisms that demand susceptibility-guided therapy and sometimes the use of investigational agents.
5. A combination of antifungals, such as systemic isavuconazole with topical amphotericin B and surgical debridement, can improve outcomes for severe or localized fungal infections.
6. For candida infections or candidemia, agents like echinocandins are frontline therapies in the United States according to the available research.
7. The risk of the fungi spreading increases with Thommy Schmelz's treatment, and the required medications can only be given in small doses due to his weakened overall condition.
8. In an attempt to find alternative help, Mermi-Schmelz is conducting research on therapies and treatments, focusing on eye-health, skin-care, and mental-health, which are vital components of health-and-wellness.
9. Mermi-Schmelz has contacted doctors in Brazil and Charité in Berlin, but they are at a loss, showing the complexity of treating double fungal infections, especially because the specific pathogens in Thommy Schmelz’s case were not detailed in the search results.
10. Early diagnosis, combined systemic antifungal therapy, and, if feasible, surgical intervention are the pillars of managing double fungal infections in critically ill patients, as per current research and medical literature on workplace-wellness.
11. Meanwhile, famous wrestler Hulk Hogan passed away, a fact that is not directly related to the current situation of Thommy Schmelz.
12. Breathing fitness-and-exercise, consuming proper nutrition, and maintaining good skin-care are practices that can positively impact mens-health, womens-health, and parenting while aging, which can contribute to overall wellness, even in challenging times like this.

Read also: